These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 16204712)

  • 1. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
    Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
    J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
    Borroni B; Anchisi D; Paghera B; Vicini B; Kerrouche N; Garibotto V; Terzi A; Vignolo LA; Di Luca M; Giubbini R; Padovani A; Perani D
    Neurobiol Aging; 2006 Jan; 27(1):24-31. PubMed ID: 16298237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
    Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
    Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
    J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral glucose metabolism in patients with AD and different APOE genotypes.
    Drzezga A; Riemenschneider M; Strassner B; Grimmer T; Peller M; Knoll A; Wagenpfeil S; Minoshima S; Schwaiger M; Kurz A
    Neurology; 2005 Jan; 64(1):102-7. PubMed ID: 15642911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.
    Barabash A; Marcos A; Ancín I; Vázquez-Alvarez B; de Ugarte C; Gil P; Fernández C; Encinas M; López-Ibor JJ; Cabranes JA
    Neurobiol Aging; 2009 Aug; 30(8):1254-64. PubMed ID: 18078695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease.
    Ponomareva NV; Korovaitseva GI; Rogaev EI
    Neurobiol Aging; 2008 Jun; 29(6):819-27. PubMed ID: 17293007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of delayed episodic memory in patients with mild cognitive impairment--a FDG PET study.
    Schönknecht OD; Hunt A; Toro P; Henze M; Haberkorn U; Schröder J
    Neurosci Lett; 2009 Dec; 467(2):100-4. PubMed ID: 19819300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of APOE genotypes in a memory clinic cohort.
    van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P
    Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
    Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
    J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment.
    Caselli RJ; Chen K; Lee W; Alexander GE; Reiman EM
    Arch Neurol; 2008 Sep; 65(9):1231-6. PubMed ID: 18779428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.